Anúncio
Anúncio
LLY
Eli Lilly & Co.
1064.01
USDPatrocinado
+22.50
+2.16%
06 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1067.14
+3.13
+0.29%
Relatórios de Lucros LLY
Rácio de surpresa positiva
LLY separação 27 de 39 últimas estimativas.
69%
Próximo Relatório
Data do Próximo Relatório
04 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$17.96B
/$7.14
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+2.06%
/+1.71%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+32.74%
/+34.21%
Eli Lilly & Co. earnings per share and revenue
On 30 de out. de 2025, LLY reported earnings of 7.02 USD per share (EPS) for Q3 25, beating the estimate of 5.75 USD, resulting in a 22.05% surprise. Revenue reached 17.60 bilhão, compared to an expected 16.18 bilhão, with a 8.81% difference. The market reacted with a +3.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 20 analistas forecast an EPS of 7.14 USD, with revenue projected to reach 17.96 bilhão USD, implying an aumentar of 1.71% EPS, and aumentar of 2.06% in Revenue from the last quarter.
FAQ
What were Eli Lilly & Co.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Eli Lilly & Co. reported EPS of $7.02, beating estimates by 22.05%, and revenue of $17.60B, 8.81% above expectations.
How did the market react to Eli Lilly & Co.'s Q3 2025 earnings?
The stock price moved up 3.81%, changed from $813.53 before the earnings release to $844.50 the day after.
When is Eli Lilly & Co. expected to report next?
The next earning report is scheduled for 04 de fev. de 2026.
What are the forecasts for Eli Lilly & Co.'s next earnings report?
Based on 20
analistas, Eli Lilly & Co. is expected to report EPS of $7.14 and revenue of $17.96B for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio